Mono Pharmacare (MONOPHARMA)
STALWARTScore breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹12.9 |
| Market Cap | ₹22.97 Cr |
| P/E Ratio | 27.67 |
| ROCE | 11% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -99.13% |
| Debt/Equity | — |
| Sales Growth | -23.94% |
| 52-Week Range | ₹9.45 — ₹27.5 |
| Sector | Pharmaceuticals & Biotechnology |
Mono Pharmacare trades with a P/E ratio of 27.67, ROCE of 11%, profit growth of -99.13%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer